Literature DB >> 1353248

Up-regulation of N-methyl-D-aspartate receptors on cultured cortical neurons after exposure to antagonists.

K Williams1, M A Dichter, P B Molinoff.   

Abstract

The density of N-methyl-D-aspartate (NMDA) receptors on membranes prepared from cultured cortical neurons was determined using binding assays with [125I]I-MK-801 after exposure of cultures to antagonists of the NMDA receptor complex. The density of binding sites for [125I]I-MK-801 was increased by 40-80% after exposure to D-2-amino-5-phosphonopentanoic acid (D-AP5), with no change in the number or viability of neurons. The effect of D-AP5 was concentration dependent, with an EC50 of 10 microM. Up-regulation of NMDA receptors was observed after 2-7 days but not after 1 day of exposure to 100 microM D-AP5. The density of NMDA receptors was also increased after exposure of cells to CGS 19755 and MK-801 but not after exposure to the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione. The binding of [3H]AMPA was unaltered after exposure to D-AP5. These results demonstrate that the density of NMDA receptors on cultured neurons can be selectively up-regulated by exposure to NMDA receptor antagonists. Increases in the density of NMDA receptors occurring in vivo could complicate therapeutic approaches to the treatment of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353248

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain.

Authors:  Lana J Mawhinney; Juan Pablo de Rivero Vaccari; Ofelia F Alonso; Christopher A Jimenez; Concepción Furones; W Javier Moreno; Michael C Lewis; W Dalton Dietrich; Helen M Bramlett
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

2.  The expression of NMDA receptor subunits in cerebral cortex and hippocampus is differentially increased by administration of endobain E, a Na+, K+-ATPase inhibitor.

Authors:  María Geraldina Bersier; Clara Peña; Georgina Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  2007-08-08       Impact factor: 3.996

3.  Differential subcellular regulation of NMDAR1 protein and mRNA in dendrites of dentate gyrus granule cells after perforant path transection.

Authors:  A H Gazzaley; D L Benson; G W Huntley; J H Morrison
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

4.  Identification of in vivo, conserved, TAF15 RNA binding sites reveals the impact of TAF15 on the neuronal transcriptome.

Authors:  Fadia Ibrahim; Manolis Maragkakis; Panagiotis Alexiou; Margaret A Maronski; Marc A Dichter; Zissimos Mourelatos
Journal:  Cell Rep       Date:  2013-02-14       Impact factor: 9.423

5.  Regulation of ERK phosphorylation by ethanol in fetal cortical neurons.

Authors:  Haviryaji S G Kalluri; Maharaj K Ticku
Journal:  Neurochem Res       Date:  2003-05       Impact factor: 3.996

6.  Glutamate receptors in alcohol withdrawal-induced neurotoxicity.

Authors:  P L Hoffman
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

7.  Gene expression profiling in the developing rat brain exposed to ketamine.

Authors:  Q Shi; L Guo; T A Patterson; S Dial; Q Li; N Sadovova; X Zhang; J P Hanig; M G Paule; W Slikker; C Wang
Journal:  Neuroscience       Date:  2010-01-18       Impact factor: 3.590

8.  Potential neurotoxicity of ketamine in the developing rat brain.

Authors:  Xiaoju Zou; Tucker A Patterson; Natalya Sadovova; Nathan C Twaddle; Daniel R Doerge; Xuan Zhang; Xin Fu; Joseph P Hanig; Merle G Paule; William Slikker; Cheng Wang
Journal:  Toxicol Sci       Date:  2009-01-06       Impact factor: 4.849

9.  Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats.

Authors:  Ziphozethu Ndlazi; Oualid Abboussi; Musa Mabandla; Willie Daniels
Journal:  AIMS Neurosci       Date:  2018-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.